Medpace Holdings, Inc. Insider Trading Activity

DAVENPORT FRED B JR reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 05/18/2026 - 05:04 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

DAVENPORT FRED B JR reported acquisition or exercise transactions in this Form 4 filing.

Medpace Holdings, Inc. director Fred B. Davenport Jr. received a grant of 1,110 stock options to buy common stock at $415.2700 per share, expiring on May 15, 2033. The options vest on the earlier of the day immediately preceding the first annual meeting following the grant date or the first anniversary of the grant, subject to his continued board service. Following this grant, he holds 3,498 shares directly and 2,000 shares indirectly through a trust.

Insider Trade Summary

Grant/Award: 1,110 shares

Grant/Award 1 txn

Insider DAVENPORT FRED B JR

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	1,110	$0.00	$0.00
Holding	Common Stock	--	--	--
Holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 1,110 contracts (Direct); Common Stock — 3,498 shares (Direct); Common Stock — 2,000 shares (Indirect, By Trust)

Holdings Before and After: Stock Option (Right to Buy), 0 to 1,110 contracts (Direct)

Footnotes (2)

1. F1. Owned by trust for the benefit of the Reporting Person.
2. F2. The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

Key Figures

Stock options granted: 1,110 options Option exercise price: $415.2700 per share Option expiration date: May 15, 2033 +2 more

5 metrics

Stock options granted 1,110 options Grant to director on May 15, 2026

Option exercise price $415.2700 per share Strike price for Medpace common stock

Option expiration date May 15, 2033 Expiration of granted options

Direct common shares 3,498 shares Direct holdings after reported transactions

Indirect common shares 2,000 shares Held by trust for reporting person

Key Terms

Stock Option (Right to Buy), grant/award acquisition, exercise price, vesting date, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title": "Stock Option (Right to Buy)""

grant/award acquisition financial

"transaction_action": "grant/award acquisition""

exercise price financial

"conversion_or_exercise_price": "415.2700""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting date financial

"through the vesting date."

Owned by trust financial

"Owned by trust for the benefit of the Reporting Person."

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DAVENPORT FRED B JR

(Last) (First) (Middle)

C/O MEDPACE HOLDINGS, INC.

5375 MEDPACE WAY

(Street)

CINCINNATI OHIO 45227

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Medpace Holdings, Inc. [ MEDP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								3,498	D
Common Stock								2,000	I	By Trust(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$415.27	05/15/2026		A		1,110		(2)	05/15/2033	Common Stock	1,110	$0	1,110	D

Explanation of Responses:

1. Owned by trust for the benefit of the Reporting Person.

2. The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

Remarks:

	/s/ Stephen P. Ewald, Attorney-in-Fact for Fred B. Davenport, Jr.	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)